Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/69236
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | The ADAMTS1 protease gene is required for mammary tumor growth and metastasis |
Author: | Ricciardelli, C. Frewin, K. Tan, I. Williams, E. Opeskin, K. Pritchard, M. Ingman, W. Russell, D. |
Citation: | American Journal of Pathology, 2011; 179(6):3075-3085 |
Publisher: | Amer Soc Investigative Pathology Inc |
Issue Date: | 2011 |
ISSN: | 0002-9440 1525-2191 |
Statement of Responsibility: | Carmela Ricciardelli, Kate M. Frewin, Izza de Arao Tan, Elizabeth D. Williams, Kenneth Opeskin, Melanie A. Pritchard, Wendy V. Ingman, and Darryl L. Russell |
Abstract: | A disintegrin and metalloprotease with thrombospondin motifs protein 1 (ADAMTS1) is a protease commonly up-regulated in metastatic carcinoma. Its overexpression in cancer cells promotes experimental metastasis, but whether ADAMTS1 is essential for metastatic progression is unknown. To address this question, we investigated mammary cancer progression and spontaneous metastasis in the MMTV-PyMT mouse mammary tumor model in Adamts1 knockout mice. Adamts1(-/-)/PyMT mice displayed significantly reduced mammary tumor and lung metastatic tumor burden and increased survival, compared with their wild-type and heterozygous littermates. Histological examination revealed an increased proportion of tumors with ductal carcinoma in situ and a lower proportion of high-grade invasive tumors in Adamts1(-/-)/PyMT mice, compared with Adamts1(+/+)/PyMT mice. Increased apoptosis with unaltered proliferation and vascular density in the Adamts1(-/-)/PyMT tumors suggested that reduced cell survival accounts for the lower tumor burden in ADAMTS1-deficient mice. Furthermore, Adamts1(-/-) tumor stroma had significantly lesser amounts of proteolytically cleaved versican and increased numbers of CD45(+) leukocytes. Characterization of immune cell gene expression indicated that cytotoxic cell activation was increased in Adamts1(-/-) tumors, compared with Adamts1(+/+) tumors. This finding is supported by significantly elevated IL-12(+) cell numbers in Adamts1(-/-) tumors. Thus, in vivo ADAMTS1 may promote mammary tumor growth and progression to metastasis in the PyMT model and is a potential therapeutic target to prevent metastatic breast cancer. |
Keywords: | T-Lymphocytes Th1 Cells Animals Mice, Inbred C57BL Mice, Knockout Mice Mammary Neoplasms, Experimental Lung Neoplasms Lymphatic Metastasis Disease Progression Neovascularization, Pathologic Tumor Burden Apoptosis Cell Proliferation Female ADAM Proteins Versicans Kaplan-Meier Estimate ADAMTS1 Protein Leukocyte Common Antigens |
Rights: | Copyright © 2011 American Society for Investigative Pathology. |
DOI: | 10.1016/j.ajpath.2011.08.021 |
Description (link): | http://www.elsevier.com/wps/find/journaldescription.cws_home/724906/description#description |
Published version: | http://dx.doi.org/10.1016/j.ajpath.2011.08.021 |
Appears in Collections: | Aurora harvest Obstetrics and Gynaecology publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.